Assignee
THE WISTAR INST
US·11 granted patents·9 pending applications·6 citations·filing 2014–2025
Top patents by PatentIndex Score
20 records- 0188US9624510B2Adenoviral vectors comprising partial deletions of E3THE WISTAR INST·Filed 2014·Granted Apr 18, 2017·6 cites·13 claims
- 0287US2025354172A1Adenoviral Vectors Comprising Partial Deletions of E3THE WISTAR INST·Filed 2025·Application pending·0 cites
- 0385US12391959B2Adenoviral vectors comprising partial deletions of E3THE WISTAR INST·Filed 2023·Granted Aug 19, 2025·0 cites·6 claims
- 0473US11702675B2Adenoviral vectors comprising partial deletions of E3THE WISTAR INST·Filed 2020·Granted Jul 18, 2023·0 cites·11 claims
- 0573US10822619B2Adenoviral vectors comprising partial deletions of E3THE WISTAR INST·Filed 2019·Granted Nov 3, 2020·0 cites·13 claims
- 0670US12116359B2EBNA1 inhibitor crystalline forms, and methods of preparing and using sameTHE WISTAR INST·Filed 2022·Granted Oct 15, 2024·0 cites·10 claims
- 0768US2024216346A1Substituted Chromenones, IRE1 Inhibitors, and Methods of Using SameTHE WISTAR INST·Filed 2023·Application pending·0 cites
- 0865US10407696B2Adenoviral vectors comprising partial deletions of E3THE WISTAR INST·Filed 2017·Granted Sep 10, 2019·0 cites·12 claims
- 0963US12544433B2Melanoma canine vaccine compositions and methods of use thereofTHE WISTAR INST·Filed 2019·Granted Feb 10, 2026·0 cites·21 claims
- 1063US11242338B2EBNA1 inhibitor crystalline forms, and methods of preparing and using sameTHE WISTAR INST·Filed 2019·Granted Feb 8, 2022·0 cites·25 claims
- 1162US2023159602A1Engineered optimized cytokine compositionsTHE WISTAR INST·Filed 2022·Application pending·0 cites
- 1262US2023277569A1Compositions and Methods for Treating, Ameliorating and/or Preventing Cancer and Kits for the SameTHE WISTAR INST·Filed 2023·Application pending·0 cites
- 1359US11833137B2Substituted chromenones, IRE1 inhibitors, and methods of using sameTHE WISTAR INST·Filed 2019·Granted Dec 5, 2023·0 cites·20 claims
- 1457US2024181041A1Adenovirus SARS-CoV-2 VaccineTHE WISTAR INST·Filed 2022·Application pending·0 cites
- 1553US2025243168A1Acetyl-coa synthetase 2 (acss2) inhibitors and methods using sameTHE WISTAR INST·Filed 2025·Application pending·0 cites
- 1651US2022211835A1Replication Deficient Adenoviral Vectors for HIV Vaccine ApplicationsTHE WISTAR INST·Filed 2019·Application pending·0 cites
- 1750US12281084B2Acetyl-CoA synthetase 2 (ACSS2) inhibitors and methods using sameTHE WISTAR INST·Filed 2020·Granted Apr 22, 2025·0 cites·20 claims
- 1850US2021101952A1Engineered Optimized Cytokine CompositionsTHE WISTAR INST·Filed 2019·Application pending·0 cites
- 1949US12595293B2Anti-follicle stimulating hormone receptor antibodiesTHE WISTAR INST·Filed 2019·Granted Apr 7, 2026·0 cites·14 claims
- 2048US2023158146A1HSP70 Inhibitors and Methods of Using SameTHE WISTAR INST·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when THE WISTAR INST files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →